Literature DB >> 3542447

Antidiarrheal therapy. Prospects for new agents.

R N Fedorak, M Field.   

Abstract

Successful treatment of severe diarrhea has traditionally relied upon opiates or opiate derivatives. Recent advances in our understanding of intestinal fluid and electrolyte absorption have provided the opportunity to develop therapeutic agents specific for various points in the secretory and absorptive process. Present and proposed antidiarrheal agents, in addition to antimotility activity, will be capable of stimulating intestinal fluid absorption, inhibiting intestinal fluid secretion, or both. The mechanism(s) of action and clinical implications for proposed antidiarrheal agents are reviewed.

Entities:  

Keywords:  Biology; Diarrhea--prevention and control; Diseases; Drugs; Physiology; Research Methodology; Treatment

Mesh:

Substances:

Year:  1987        PMID: 3542447     DOI: 10.1007/BF01297108

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  82 in total

1.  Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine.

Authors:  J Holmgren; S Lange; I Lönnroth
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

2.  Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut.

Authors:  J Alumets; F Sundler; R Håkanson
Journal:  Cell Tissue Res       Date:  1977-12-28       Impact factor: 5.249

3.  Antagonism of cholera enterotoxin by anti-inflammatory agents in the rat.

Authors:  H I Jacoby; C H Marshall
Journal:  Nature       Date:  1972-01-21       Impact factor: 49.962

4.  Studies on role of calmodulin in Ca2+ regulation of rabbit ileal Na and Cl transport.

Authors:  M Donowitz; J Wicks; J L Madara; G W Sharp
Journal:  Am J Physiol       Date:  1985-06

5.  Salicylate other than 5-aminosalicylic acid ineffective in ulcerative colitis.

Authors:  M Campieri; G A Lanfranchi; G Bazzocehi; C Brignola; G Corazza; C Cortini; M Michelini; G Labó
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

6.  Adrenergic mediation of the intestinal antisecretory action of opiates administered into the central nervous system.

Authors:  D R Brown; R J Miller
Journal:  J Pharmacol Exp Ther       Date:  1984-10       Impact factor: 4.030

7.  Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.

Authors:  D S Rampton; G E Sladen
Journal:  Prostaglandins       Date:  1981-03

8.  Chlorpromazine reduces fluid-loss in cholera.

Authors:  G H Rabbani; W B Greenough; J Holmgren; I Lönnroth
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

9.  An experiment to determine the active therapeutic moiety of sulphasalazine.

Authors:  A K Azad Khan; J Piris; S C Truelove
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

10.  Evaluation of BW942C, a novel antidiarrheal agent, against enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  D R Morgan; J Sellin; L Gutierrez; H L DuPont; L V Wood
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

View more
  3 in total

Review 1.  Rational pharmacotherapy of gastrointestinal motility disorders.

Authors:  P Demol; H J Ruoff; T R Weihrauch
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

2.  What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans.

Authors:  Konstantinos C Fragkos; Natalia Zárate-Lopez; Christos C Frangos
Journal:  Therap Adv Gastroenterol       Date:  2016-01-25       Impact factor: 4.409

Review 3.  Treatment of diarrhea of neonatal calves.

Authors:  A J Roussel; G W Brumbaugh
Journal:  Vet Clin North Am Food Anim Pract       Date:  1991-11       Impact factor: 3.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.